Xcout Intel
Tandem Diabetes Care, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Tandem Diabetes Care, Inc. among medical devices companies — ranked by similarity to what Tandem Diabetes Care, Inc. actually does, not by market-cap band.
Subscribe to see Tandem Diabetes Care, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.
Tandem Diabetes Care, Inc. at a glance
Tandem Diabetes Care, Inc. is a medical devices company headquartered in San Diego, United States, founded in 2008. It is publicly listed (TNDM) with a market capitalisation of $1.1B. Xcout tracks 18 named people at Tandem Diabetes Care, Inc., including John F. Sheridan (President, Chief Executive Officer & Director). Xcout recorded 98 job postings from Tandem Diabetes Care, Inc. in the last 90 days, naming tools such as GitHub, Salesforce, Datadog.
Tandem Diabetes Care, Inc. leadership
- John F. SheridanPresident, Chief Executive Officer & Director
- Jean-Claude E. KyrillosExecutive Vice President & Chief Operating Officer
- Leigh A. VossellerExecutive Vice President, Chief Financial Officer & Treasurer
- Rick A. CarpenterExecutive VP & CTO
- Elizabeth Anne GasserExecutive Vice President and Chief Strategy & Product Officer
- Shannon HansenExecutive Vice President, Chief Legal, Privacy & Compliance Officer and Secretary
12 more named people on record for Tandem Diabetes Care, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Tandem Diabetes Care, Inc.
Xcout recorded 98 job postings from Tandem Diabetes Care, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Tandem Diabetes Care, Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see Tandem Diabetes Care, Inc.'s hiring signals →
Top 12 Tandem Diabetes Care, Inc. competitors
Ranked by semantic similarity — how close each company is to Tandem Diabetes Care, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
Ottai provides a continuous glucose monitoring system and companion app designed for 24/7 glucose tracking. The company serves individuals managing diabetes by offering wearable devices and AI-powered insights to help monitor glucose fluctuations and build healthier habits without the need for finger pricks.
Similar medical devices company
Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts are dedicated to supplying remote monitoring capabilities to the medical, healthcare, and individual consumer markets, encompassing both diagnostic tools and ongoing management support for chronic and lifestyle-related conditions. Among its key offerings are the Bioflux mobile cardiac telemetry solution, an integrated ECG device, alongside specialized ECG analysis software designed to process and synthesize patient heart rhythm data, complemented by various software components.
Similar medical devices company
iRhythm Technologies, Inc. is headquartered in San Francisco, United States, and focuses on the provision of ambulatory ECG monitoring products and digital healthcare solutions for cardiac care.
Similar medical devices company
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Similar medical devices company
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Similar medical devices company
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Similar medical devices company
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Medical Devices & Diabetes Care
Geffen Medical is an Israeli company that provides advanced diabetes management technologies, including the FreeStyle Libre and Omnipod systems.
Similar medical devices company
MicroTech Medical (Hangzhou) Co., Ltd. focuses on the innovation, production, and market distribution of essential medical devices and consumables for diabetes management. Its operations extend across the People's Republic of China and into global markets. The company offers a comprehensive range of products, including the Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, traditional blood glucose monitoring systems, and advanced closed-loop artificial pancreas technology. Beyond its core offerings, MicroTech Medical is also actively involved in engineering and technological research, experimentation, and developmental endeavors. The firm, established in 2011, maintains its headquarters in Hangzhou, People's Republic of China.
Similar medical devices company
Sinocare manufactures and provides continuous glucose monitoring (CGM) systems and related mobile applications for diabetes management.
Similar medical devices company
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
Medical Devices & Healthcare
Pharmaco Healthcare provides diabetes management products and medical devices, including insulin pumps, continuous glucose monitors, and blood glucose meters in New Zealand.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Tandem Diabetes Care, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Tandem Diabetes Care, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →